UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
|
|
|
|
|
☐ |
|
Preliminary Proxy Statement |
|
|
|
|
|
☐ |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
|
|
|
|
☐ |
|
Definitive Proxy Statement |
|
|
|
|
|
☒ |
|
Definitive Additional Materials |
|
|
|
|
|
☐ |
|
Soliciting Material Pursuant to §240.14a-12 |
EyePoint Pharmaceuticals, Inc.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
☒ |
|
No fee required. |
||
|
☐ |
|
Fee paid previously with preliminary materials. |
||
|
☐ |
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
||
|
|
|
|
||
The Sample Company + C 1234567890 000004 ENDORSEMENT_LINE______________ SACKPACK_____________ MR A SAMPLE Online DESIGNATION (IF ANY) ADD 1 Goto www.envisionreports.com/EYPT ADD 2 orscantheQR code —logindetailsarelocated ADD 3 intheshadedbarbelow. ADD 4 ADD 5 ADD 6 Stockholder Meeting Notice 123456789012345 ImportantNoticeRegardingtheAvailabilityofProxyMaterialsfor the EyePointPharmaceuticals, Inc. Stockholder MeetingtobeHeld on June 23, 2022 UnderSecuritiesandExchange Commission rules, youarereceivingthis noticethattheproxymaterials for theannual stockholders’ meeting areavailable onthe Internet. Followtheinstructionsbelowtoviewthe materialsandvote online or requestacopy. The itemstobevotedonandlocationoftheannualmeeting areonthereverseside. Yourvoteis important! Thiscommunication presentsonly anoverview ofthe morecompleteproxymaterialsthatare availableto youontheInternet. Weencourageyouto access andreviewall oftheimportantinformationcontainedintheproxy materialsbefore voting. The 2022 proxystatement and10-Kareavailableat: www.envisionreports.com/EYPT EasyOnline Access —View yourproxymaterialsandvote. Step1: Goto www.envisionreports.com/EYPT. Step2: Click on CastYourVoteorRequestMaterials. Step 3: Follow the instructions on the screen to log in. Step 4: Make your selections as instructed on each screen for your delivery preferences. Step 5: Vote your shares. Whenyougo online, youcanalso help theenvironmentby consentingtoreceiveelectronicdeliveryoffuturematerials. ObtainingaCopy ofthe ProxyMaterials –Ifyou wantto receivea copyoftheproxymaterials, youmustrequest one. Thereisno charge to youforrequesting acopy. Pleasemakeyourrequest asinstructedonthereverseside onorbeforeJune14, 2022tofacilitatetimelydelivery. 2NOT COY + 03LQLC
Stockholder MeetingNotice The2022AnnualMeetingofStockholdersofEyePointPharmaceuticals will beheldonJune23, 2022at9:00am EasternTime, virtually via theinternet at www.meetnow.global/MGNZNG2. To accessthevirtualmeeting, youmusthavetheinformationthatis printedinthe shadedbar locatedonthereversesideofthisform. Proposalstobe voted onatthemeeting arelistedbelowalongwiththeBoard ofDirectors’ recommendations. TheBoard of Directorsrecommend avote FOR all thedirectornominees listedin proposal 1andFOR proposals2 and 3: 1. ElectionofDirectors: 01 -GöranAndo 02 -NancyLurker 03 -JohnB. Landis 04 -DavidGuyer 05 -WendyDiCicco 06 -YeLiu 07 -Anthony P. Adamis 2. To approve, onanadvisorybasis, thecompensation paidto theCompany’snamedexecutiveofficers asdisclosedintheaccompanying proxystatement. 3. To ratifytheappointment ofDeloitte&ToucheLLPastheCompany’sindependentregisteredpublicaccountingfirmforthefiscalyearending December31, 2022. PLEASENOTE – YOU CANNOTVOTEBYRETURNINGTHIS NOTICE. Tovote yoursharesyou must go online orrequestapapercopyoftheproxymaterialsto receiveaproxycard. Here’showtoorder acopyoftheproxymaterials andselectdeliverypreferences: Currentandfuturedeliveryrequestscanbesubmittedusingtheoptionsbelow. Ifyourequestanemail copy, youwillreceiveanemailwithalinkto thecurrentmeetingmaterials. PLEASENOTE:Youmustusethenumber intheshadedbaronthereversesidewhenrequestingacopyof theproxymaterials. — Internet –Goto www.envisionreports.com/EYPT.ClickCastYourVoteorRequestMaterials. — Phone –Callusfreeof charge at1-866-641-4276. — Email–Send anemailto investorvote@computershare.comwith “ProxyMaterialsEyePoint Pharmaceuticals, Inc.” inthesubjectline. Includeyour fullnameandaddress, plusthe numberlocatedintheshadedbaronthereverseside, andstatethatyou wantapaper copyofthemeetingmaterials. To facilitatetimely delivery, allrequestsforapapercopyof proxymaterialsmustbereceived byJune 14, 2022.